Teva Pharmaceutical Industries (NYSE: TEVA)
Key Data Points
Teva Pharmaceutical Industries Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Teva Pharmaceutical Industries Company Info
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
News & Analysis
These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now
Why Teva Pharmaceutical Stock Is Sinking Today
My Top 10 Portfolio Holdings for 2025
This combination of growth and value stocks has the potential to outperform the broader market in 2025 (and beyond).
3 Bargain Stocks to Buy on the Dip
These stocks should be poised to rebound.
Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy?
It's unclear whether the pivot will be enough to halt its recent decline.
Why Teva Pharmaceutical Stock Is Jumping Today
Investors are reacting positively to Teva's new growth strategy.
1 "Safe" Stock to Avoid and 1 to Consider Buying in April
There's more to the concept of safety than having a business model that looks safe.
Better Generics Pharmaceutical Stock: Teva or Viatris?
Both have plans to return to growth.
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.